-
Roflumilast, sold
under the
brand name
Daxas among others, is a
medication used for the
treatment of
chronic obstructive pulmonary disease,
plaque psoriasis...
-
tract infections,
which have been
discovered from the
clinical use of
roflumilast. Apremilast, a
phthalimide derivative that was
approved by the U.S. FDA...
- to
AstraZeneca for $575
million (about £383 million),
which included roflumilast and ciclesonide. On November, the U.S. Food and Drug
Administration approved...
-
alleviate renal colic pain, also to
hasten cervical dilatation in
labor Roflumilast,
indicated for
people with
severe COPD to
prevent symptoms such as coughing...
-
guide appropriate treatment approaches. For example, the PDE4
inhibitor roflumilast is
targeted at the chronic-bronchitic phenotype. Two
inflammatory phenotypes...
-
Proxyphylline Pumafentrine Quazinone Quazodine Revamilast Revizinone Roflumilast Rolipram Ronomilast Saterinone Senazodan Siguazodan Tetomilast Tofimilast...
-
Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat Salbutamol/budesonide
Savolitinib Saxagliptin...
-
Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat Salbutamol/budesonide
Savolitinib Saxagliptin...
-
phosphodiesterase 4 (PDE4)
inhibitors like
apremilast (a
thalidomide derivative),
roflumilast, and the less subtype-selective PDE4 inhibitor, pentoxifylline, have...
-
chronic bronchitic phenotype of COPD, the phosphodiesterase-4
inhibitor roflumilast may
decrease significant exacerbations.
Chronic bronchitis affects about...
